ʻO ka hōʻailona no ka adrenaline nasal spray ʻO Neffy ua hoʻonui ʻia (e ka US FDA) e hoʻokomo i nā keiki ʻehā makahiki a ʻoi aku ka nui o ke kaumaha ma mua o 15 kg.
Ma mua o ka lā 9 ʻAukake 2025, ʻO Neffy ua ʻae ʻia no ka mālama ʻana i nā maʻi maʻi ʻano 1, me nā mea e hoʻoweliweli ana i ke ola anaphylaxis, i nā pākeke a me nā keiki i ka liʻiliʻi o 30 kg (66 paona). ʻO ia ka lāʻau ihu mua i ʻae ʻia e FDA e mālama i ka anaphylaxis a me ka huahana epinephrine mua no ka mālama ʻana i ka anaphylaxis ʻaʻole i lawelawe ʻia e ka inikia.
Ma ka la 28 o Iune 2024, Eurneffy, ʻo ka nasal adrenaline spray mua no ka mālama ʻana i ka ulia pōpilikia e kūʻē i nā hopena maʻi (anaphylaxis) i hāʻawi ʻia i ka mana kūʻai ma ka European Union (EU) e ka European Medicine Agency (EMA).
Ke kali nei ka adrenaline nasal spray no ka mālama ʻana i ka maʻi maʻi (anaphylaxis) ma United Kingdon a me Kanada.
ʻO ka ʻae ʻana o ka adrenaline nasal spray no ka mālama ʻana i ka pilikia e kūʻē i nā hopena maʻi e hāʻawi i kahi ala ʻē aʻe o ka hoʻoponopono ʻana i ka adrenaline i ka poʻe (ʻoi aku i nā keiki) hōʻole i nā injections a ke alo nei lākou i kahi kūlana weliweli o ka anaphylaxis.
ʻO Adrenaline (ʻike ʻia ʻo epinephrine) ʻo ia wale nō ka mālama ola no ka anaphylaxis. Loaʻa ia i kēia manawa ma ke ʻano he injection maʻamau e lawelawe ʻia ma ke ala intramuscular (IM) a i ʻole intravenous (IV). Neffy/Eurneffy ʻo ia ka huahana epinephrine mua no ka mālama ʻana i ka anaphylaxis ʻaʻole i lawelawe ʻia e ka injection. He hoʻokahi hoʻoheheʻe ihu i hoʻokomo ʻia i loko o ka puka ihu hoʻokahi. Hiki ke hā'awi 'ia ka ma'i lua (e ho'ohana ana i ka pulu ihu hou i ka puka ihu ho'okahi) inā 'a'ole i ho'omaika'i 'ia nā hō'ailona a i 'ole e pi'i a'e nā hō'ailona. Pono paha nā maʻi e ʻimi i ke kōkua olakino no ka nānā pono ʻana.
Manaʻo ʻia ʻo Anaphylaxis he pilikia olakino. He maʻi maʻi koʻikoʻi, hoʻoweliweli i ke ola e pili ana i nā ʻāpana he nui o ke kino. ʻO kekahi mau meaʻai, nā lāʻau lapaʻau, a me nā ʻuu pepeke he mau allergens maʻamau i hiki ke hoʻoulu i ka anaphylaxis. Hōʻike pinepine ʻia nā hōʻailona i loko o nā minuke o ka hoʻolaha ʻana a hoʻokomo ʻia, akā ʻaʻole i kaupalena ʻia i nā hives, pehu, ʻili, luaʻi, pilikia ka hanu a me ka nalo ʻana o ka ʻike.
***
E hoʻomaopopo ':
- Hoʻokuʻu ʻia ʻo FDA News -FDA Roundup: 7 Malaki 2025. Loaʻa ma https://www.fda.gov/news-events/press-announcements/fda-roundup-march-7-2025
- EMA. Nūhou - ʻO ka nasal adrenaline spray mua no ka mālama ʻana i ka maʻi maʻi. Hoʻopuka ʻia 28 Iune 2024. Loaʻa ma https://www.ema.europa.eu/en/news/first-nasal-adrenaline-spray-emergency-treatment-against-allergic-reactions
- ARS Pharmaceuticals Files no ka ʻae ʻana o neffy® ma Kanada a me United Kingdom ma ka ʻaoʻao o ka Hoa Laikini ALK-Abelló A/S. Hoʻopuka ʻia 6 Ianuali 2025. Loaʻa ma https://ir.ars-pharma.com/news-releases/news-release-details/ars-pharmaceuticals-files-approval-neffyr-canada-and-united
***
Pākuʻi pili
- He Lapaau maalahi hou no ka ma'i ma'i pī (15 Nowemapa 2018)
***
